August 2026
Industry newsRevolution Medicines' Rasonque was approved as the first RAS-targeted therapy for metastatic pancreatic cancer, a disease that has had very few targeted treatment options. Approvals like this often open new recruiting trials — search ClinicalMatch to see what's currently enrolling for pancreatic cancer.
Source: Cancer Therapy Advisor — FDA Oncology Drug Approvals 2026 ↗August 2026
Industry newsZenbexus (iberdomide), used together with daratumumab and dexamethasone, received accelerated FDA approval for multiple myeloma this month. If this is relevant to you or someone you're caring for, ClinicalMatch's search can show related trials that are currently recruiting.
Source: Cancer Therapy Advisor — FDA Oncology Drug Approvals 2026 ↗August 2026
Industry newsThe Phase II FRUITFUL trial is evaluating fruquintinib combined with FOLFIRI chemotherapy as a second-line treatment for metastatic colorectal cancer — one of several active studies we're tracking this month. Search ClinicalMatch for colorectal cancer trials that may be recruiting near you.
Source: Fight Colorectal Cancer — August 2026 Clinical Trials Roundup ↗August 2026
ClinicalMatch updateWe've submitted the site to Google Search Console so people can find ClinicalMatch through a search, not just a direct link. New sites can take Google a little while to fully crawl and index, so don't worry if it doesn't show up in results on day one.
August 2026
ClinicalMatch updateThe site now goes beyond search: a plain-language explanation of how matching works, answers to the questions we hear most, the story behind why we're building this, and a way to reach the team directly. Patient and HCP waitlist pages are also open for early pilot access.
August 2026
ClinicalMatch updateA contact form is live for patients, caregivers, clinicians, and partners — questions, feedback, and pilot interest all reach us the same way. We read everything and aim to reply within 2 business days.
July 2026
ClinicalMatch updateOur first milestone is live: anyone can now search actively recruiting U.S. cancer trials in plain language, filtered by condition, keywords, and distance — no account needed. Data comes directly from ClinicalTrials.gov and refreshes continuously. Try it and tell us what's confusing — that feedback shapes what we build next.
July 2026
ClinicalMatch updateFewer than 5% of U.S. cancer patients ever join a clinical trial, while research sites struggle to fill the very same studies. After fifteen years planning global trials, our founder saw the disconnect up close — and started building the navigator she wished patients had. Read the full story on our About page.
Coming soon
ClinicalMatch updateNext on the roadmap: free patient accounts with saved trials, status-change alerts, and profile-based matching against fully structured eligibility criteria. Join the waitlist from the Patient Log In page to get early access.